Pediatric Microbiota SCTBo

Proud of these results!! ansa.it/emiliaromagna/…

🆕 in @BloodJournal: Increased gut microbiome diversity may lead to better outcomes among children receiving stem cell transplants. Read more: loom.ly/XJqZlOs

Very proud to share our new paper in Blood Journal! First time in children Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as predictor of mortality in children ashpublications.org/blood/article/…

Very proud to share our new paper! Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis ashpublications.org/bloodadvances/…

The difference between Knowledge and Experience.

First time at EHA congress Amazing microbiome session at #EHA2023 in Frankfurt Thanks to @young_eha @EHA_Hematology @PedMicroSCTBo @ZaninettiCarlo @TerezaFaitova @MelodySmithMD

We are very happy to share our new paper on Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML! ashpublications.org/bloodadvances/…

Lithium attenuates graft-versus-host disease via effects on the intestinal stem cell niche loom.ly/L9JZ5PQ

La leucemia mieloide acuta è un tumore raro del sangue ancora da studiare. Nasce la Rete italiana “PALM” di istituti specializzati in campo oncoematologico coordinata dall’ @bambinogesu , finanziata da Fondazione Umberto Veronesi➡bit.ly/3QZ4fLv

"The person-to-person transmission landscape of the gut and oral microbiomes". Our work on microbiome stransmission published today open-access in @Nature! Fantastic work @MireiaVallesc, the whole @cibiocm group @CIBIO_UniTrento and all the collaborators! nature.com/articles/s4158…

There is an unmet need for better methods of diagnosing GvHD, identifying at-risk patients & determining which patients are at highest risk of severity & poor outcomes. Read about updated GVHD biomarkers on Nucleus: ow.ly/GrEX50Mvl10

Good mourning researchers 🤣🤣

Very happy to share our paper on effect of levofloxacin prophylaxis and parenteral nutrition on intestinal microbial in pediatric patients undergoing HSCT… we test a new network approach! #microbiota nature.com/articles/s4200…

Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease loom.ly/0X2SAuI #SCD

Very interesting pov ‘Disruptive’ science has declined — and no one knows why nature.com/articles/d4158…

Salutiamo Gianluca Vialli con le parole che lui ha dedicato ai nostri ricercatori e alle nostre ricercatrici solo pochi mesi fa. Ci stringiamo alla sua famiglia in questo momento.

Pharmacomicrobiomics in Pediatric Oncology: The Complex Interplay between Commonly Used Drugs and Gut Microbiome mdpi.com/1989612 #mdpiijms via @IJMS_MDPI

Interesting paper on mycobiome in #fmt Profiling the fungal microbiome after FMT for graft-versus-host disease: insights from a phase 1 interventional study - ScienceDirect sciencedirect.com/science/articl…

High dose cyclophosphamide (HiCY) has changed landscape of alloBMT by expanding donor pool and allowing for relative safe and effective use of haplo donors. Esp useful in non-malig dz such as SAA and SCD where cure rates now approach 90%. Why does HiCY work?

Knowledge isn't free. You have to pay attention.